Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Berger

Showing results (631-640 of 774) with videos related to

Pageof 78
Sort By:
JACC. Cardiovascular Interventions|February 18, 2014
Utilization of radial artery access for percutaneous coronary intervention for ST-segment elevation myocardial infarction in New YorkEdward L Hannan, Louise Szypulski Farrell, Gary Walford, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 31, 2003
Cabergoline versus levodopa monotherapy: a decision analysisAntje M Smala, E Annika Spottke, Olaf Machat, et al.
The American Journal of Cardiology|May 25, 2022
Relation of Operator Volume and Access Site to Short-Term Mortality in Radial Versus Femoral Access for Primary Percutaneous Coronary InterventionEdward L Hannan, Ye Zhong, Frederick S K Ling, et al.
Circulation. Cardiovascular Interventions|January 9, 2019
Treatment of Coronary Artery Disease and Acute Myocardial Infarction in Hospitals With and Without On-Site Coronary Artery Bypass Graft SurgeryEdward L Hannan, Ye Zhong, Yifeng Wu, et al.
Journal of the American College of Cardiology|December 8, 2004
Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularizationDavid E Kandzari, Peter B Berger, Adnan Kastrati, et al.
Journal of the American College of Cardiology|November 3, 2004
Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trialPatricia J M Best, Peter B Berger, Barry R Davis, et al.
European Heart Journal|March 1, 2005
One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrelAlbert Schömig, Claus Schmitt, Alban Dibra, et al.
Circulation|May 15, 1995
Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from The TIMI II StudyF V Aguirre, L T Younis, B R Chaitman, et al.
Lancet (London, England)|January 11, 1997
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trialD R Holmes, R M Califf, F Van de Werf, et al.
Current Medical Research and Opinion|January 1, 1990
Depression in general practice: a comparison of flupenthixol dihydrochloride and dothiepin hydrochlorideV S Dwivedi, A B Berger, T K Khong, et al.
Pageof 78

Showing results (631-640 of 774) with videos related to

Sort By:
Pageof 78
JACC. Cardiovascular Interventions|February 18, 2014
Utilization of radial artery access for percutaneous coronary intervention for ST-segment elevation myocardial infarction in New YorkEdward L Hannan, Louise Szypulski Farrell, Gary Walford, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 31, 2003
Cabergoline versus levodopa monotherapy: a decision analysisAntje M Smala, E Annika Spottke, Olaf Machat, et al.
The American Journal of Cardiology|May 25, 2022
Relation of Operator Volume and Access Site to Short-Term Mortality in Radial Versus Femoral Access for Primary Percutaneous Coronary InterventionEdward L Hannan, Ye Zhong, Frederick S K Ling, et al.
Circulation. Cardiovascular Interventions|January 9, 2019
Treatment of Coronary Artery Disease and Acute Myocardial Infarction in Hospitals With and Without On-Site Coronary Artery Bypass Graft SurgeryEdward L Hannan, Ye Zhong, Yifeng Wu, et al.
Journal of the American College of Cardiology|December 8, 2004
Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularizationDavid E Kandzari, Peter B Berger, Adnan Kastrati, et al.
Journal of the American College of Cardiology|November 3, 2004
Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trialPatricia J M Best, Peter B Berger, Barry R Davis, et al.
European Heart Journal|March 1, 2005
One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrelAlbert Schömig, Claus Schmitt, Alban Dibra, et al.
Circulation|May 15, 1995
Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from The TIMI II StudyF V Aguirre, L T Younis, B R Chaitman, et al.
Lancet (London, England)|January 11, 1997
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trialD R Holmes, R M Califf, F Van de Werf, et al.
Current Medical Research and Opinion|January 1, 1990
Depression in general practice: a comparison of flupenthixol dihydrochloride and dothiepin hydrochlorideV S Dwivedi, A B Berger, T K Khong, et al.
Pageof 78